BioVie closes $3M public offering of shares and warrants at $1.53/unit

BIOVIE INC.

Closed best efforts offering of 1,360,800 shares, pre-funded warrants for 600,000 shares, and 1,960,800 common warrants.
Gross proceeds of ~$3.0M; net proceeds ~$2.79M after placement agent fees and expenses.
Acuitas warrant exercise price adjusted from $10.00 to $1.53 per share due to anti-dilution provision.
Net proceeds to be used primarily for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.